HCA Healthcare, Inc. is a health care services company that operates a network of hospitals and outpatient facilities in the United States and England. The company manages general acute care hospitals, behavioral hospitals, and rehabilitation hospitals, alongside freestanding ambulatory surgery centers, endoscopy centers, emergency care facilities, urgent care clinics, diagnostic centers, and physician practices. Services include inpatient and outpatient medical and surgical care, cardiology, oncology, neurosurgery, orthopedics, obstetrics, and mental health treatment. The company also provides home health, hospice, and physical therapy services. HCA Healthcare commenced operations in 1968 through its predecessors and was incorporated in 2010.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Care Facilities Homepage hcahealthcare.com
Sector Healthcare IR page investor.hcahealthcare.com
Tags
acute care, behavioral health, ambulatory surgery, emergency care, diagnostic imaging, rehabilitation, home health, hospice, physician practices, oncology, cardiology
Press page —

Metrics

Valuation  
Market cap $ 106.665B
Market cap (USD) $ 106.665B
P/E 16.79
PEG 2.65
P/BV -13.21
P/S 1.36
P/OCF 9.55
P/FCF 17.86
Dividend yield 0.61%
Turnover / mcap —
Returns  
ROE -112.6%
ROI 16.8%
ROIC 23.4%
Profit margin 9.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 6.3%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 24
Quality score 31.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 75.6B 70.603B 64.968B 60.233B 58.752B 51.533B 51.336B 46.677B — — — 36.918B 34.182B 33.013B 29.682B 28.035B 30.052B 28.374B 26.858B 25.477B 24.455B 23.502B 21.808B 19.729B 17.953B 16.67B
Net profit 6.784B 5.76B 5.242B 5.643B 6.956B 3.754B 3.505B 3.787B 2.216B 2.89B 2.129B 1.875B 1.556B 1.605B 2.465B 1.207B 1.054B 673M 874M 1.036B 1.424B 1.246B 1.332B 833M 886M 219M
Free cash flow 7.692B 5.639B 4.687B 4.127B 5.382B 6.397B 3.444B 3.188B 2.411B 2.893B 2.359B 2.272B 1.737B 2.313B 2.254B 1.76B 1.43B 197M -48M -20M 1.567B 1.536B 328M 1.032B 43M 392M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 466.86 300.15 270.68 239.96 256.92 164.46 147.81 124.45 87.84 74.02 67.63 73.39 47.71 30.17 21.2 — — — — 43.21 — 44.05 — — — —
Price performance 12m 0.56 0.11 0.13 -0.07 0.56 0.11 0.19 0.42 0.19 0.09 -0.08 0.54 0.58 0.42 — — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 5.83B 6.5B 6.79B 7.38B 7.05B 8.1B 8.89B 9.96B 10.8B 10.9B
↳ YoY growth -1.1% +11.6% +4.4% +8.7% -4.5% +14.8% +9.8% +12.0% +8.0% +1.1%
↳ 5y CAGR +5.1% +6.8% +5.4% +5.3% +3.7% +6.8% +6.5% +8.0% +7.8% +9.0%
Borrowings, current (USD) 216M 200M 788M 145M 209M 237M 370M 2.42B 4.7B 4.89B
Borrowings, non-current (USD) 31.2B 32.9B 32B 33.6B 30.8B 34.3B 37.7B 37.2B 38.3B 41.6B
Lease liabilities (USD) — — — 2.41B 2.67B 2.87B 2.83B 2.97B 2.99B 2.96B
Cash and deposits (USD) 646M 732M 502M 621M 1.79B 1.45B 908M 935M 1.93B 1.04B
Right-of-use assets (USD) — — — 1.83B 2.02B 2.11B 2.07B 2.21B 2.13B 2.13B
Net debt (borrowings + leases - cash) (USD) 30.7B 32.3B 32.3B 35.5B 31.9B 36B 40B 41.6B 44.1B 48.4B
Cash flow detail
Operating cash flow (USD) 5.65B 5.43B 6.76B 7.6B 9.23B 8.96B 8.52B 9.43B 10.5B 12.6B
Purchases of property, plant and equipment (USD) -2.76B -3.02B -3.57B -4.16B -2.84B -3.58B -4.4B -4.74B -4.88B -4.94B
Change in receivables (cash effect) (USD) -3.25B -4.64B -423M -326M 327M -962M -797M -935M -799M -94M
Change in payables (cash effect) (USD) 144M 374M 698M 396M 1.26B 999M -296M 604M 359M 666M
Dividends paid (cash effect) (USD) — 0.00 -487M -550M -153M -624M -653M -661M -690M -679M
Share buybacks (cash effect) (USD) -2.75B -2.05B -1.53B -1.03B -441M -8.22B -7B -3.81B -6.04B -10.1B
Interest paid (cash effect) (USD) -1.67B -1.7B -1.74B -1.91B -1.61B -1.5B -1.66B -1.89B -1.94B -2.21B
Income taxes paid (cash effect) (USD) -1.26B -1.21B -872M -849M -1B -2.18B -1.18B -1.39B -1.84B -1.74B
Share-based compensation (USD) 251M 270M 268M 347M 362M 440M 341M 262M 360M 401M
Operating cash flow before change in receivables (USD) 8.9B 10.1B 7.18B 7.93B 8.91B 9.92B 9.32B 10.4B 11.3B 12.7B
Free cash flow (OCF - PPE - intangibles) (USD) 2.89B 2.41B 3.19B 3.44B 6.4B 5.38B 4.13B 4.69B 5.64B 7.69B
Income detail
Total comprehensive income (USD) 3.36B 2.8B 4.38B 4.07B 4.35B 7.82B 6.75B 6.16B 6.7B 7.86B
Comprehensive income to owners (USD) 2.82B 2.28B 3.78B 3.43B 3.71B 7.05B 5.56B 5.31B 5.8B 6.87B
Provision for credit losses (USD) 3.26B 4.04B — — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 55.6% 65.5% — — — — — — — —
Reported Feb 22, 2017 Feb 20, 2020 Feb 21, 2019 Feb 20, 2020 Feb 19, 2021 Feb 18, 2022 Feb 17, 2023 Feb 16, 2024 Feb 14, 2025 Feb 10, 2026

Operating KPIs — quarters

KPI Dec 20 Jun 21 Sep 21 Dec 21 Jun 22 Sep 22 Jun 23 Jun 24
Occupancy (%) 69.1% 68.1% 74.0% 70.2% 67.4% 70.8% 71.1% 71.9%
Reported Feb 2, 2021 Jul 20, 2021 Oct 22, 2021 Jan 27, 2022 Jul 22, 2022 Oct 21, 2022 Jul 23, 2024 Jul 23, 2024

Operating KPIs — years

KPI Dec 2018 Dec 2019 Dec 2020 Dec 2021
Occupancy (%) 56.2% 57.8% 69.1% 70.2%
Reported Jan 28, 2020 Jan 28, 2020 Feb 2, 2021 Jan 27, 2022

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Issuance of $6,500,000,000 aggregate principal amount of senior notes Overview On November 5, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $500,000,000 aggregate principal amount of its 5.200% Senior Notes due 2028 (the “2028 Notes”), (ii) $300,000,000 aggregate principal amount of its Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), (iii) $1,000,000,000 aggregate principal amount of its 5.350% Senior Notes due 2029 (the “2029 Notes”), (iv) $1,250,000,000 aggregate principal amount of its 5.500% Senior Notes due 2031 (the “2031 Notes”), (v) $1,200,000,000 aggregate principal amount of its 5.750% Senior Notes due 2033 (the “2033 Notes”), (vi) $1,500,000,000 aggregate principal amount of its 6.000% Senior Notes due 2036 (the “2036 Notes”) and (vii) $750,000,000 aggregate principal amount of its 6.500% Senior Notes due 2056 (the “2056 Notes” and, together with the 2028 Notes, the Floating Rate Notes, the 2029 Notes, the 2031 Notes, the 2033 Notes and the 2036 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor.

HCA Announces Proposed Public Offering of Senior Notes Bull 1 Bear 0 Financing

November 2, 2026

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the redemption of all or a portion of the $1.200 billion outstanding aggregate principal amount of its 4.500% senior notes due February 2027, the repayment of outstanding borrowings under its $8.000 billion commercial paper program and the repayment of any outstanding borrowings under its senior unsecured credit facility.

Mizuho Securities USA LLC, Barclays Capital Inc., BofA Securities, Inc., and Wells Fargo Securities, LLC are acting as the joint book-running managers for the offering.

The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, NY 10020, or by calling toll-free at 1-866-271-7403; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at [email protected] or telephone at 1-888-603-5847; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, by email: [email protected] or by telephone: 1-800-294-1322; or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suit 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, by email: [email protected] or by telephone (toll-free): 1-800-645-3751.

You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security or a notice of redemption of any 4.500% senior notes due February 2027 and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any notice of redemption of the 4.500% senior notes due February 2027 will be made pursuant to a separately issued notice of redemption.

**FORWARD-LOOKING STATEMENTS
**Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about HCA’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond HCA’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 10, 2026 and our other filings with the Securities and Exchange Commission. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.

All references to the “Company” and “HCA” as used throughout this press release refer to HCA Healthcare, Inc. and its affiliates.

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

Source: HCA Healthcare

View All News

Quick Links

IR Contact

615-344-2688

Send Email

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At HCA Healthcare, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to HCA Healthcare to send you the requested Investor Email Alert updates.

* Required

Email Address * Investor Alert Options *

News
Events & Presentations
Annual Reports
SEC Filings
End of Day Stock Quote
Captcha
Enter the code shown above.
*

Submit

Submit

Unsubscribe

Email Alert Sign Up Confirmation

HCA Healthcare Logo

Follow Us

Copyright 1999-2026, C-HCA, Inc; All rights reserved.

California Notice at Collection | Right to Receive Estimate | Terms of Use | Notice of Privacy Practices | Privacy Policy

| Social Media Policy | Acceptable Use Policy | Surprise Billing | Nondiscrimination Notice | Accessibility | Disclosures | Cookie Preferences

October 29, 2026

HCA Healthcare hospitals earned more 2027 specialty care recognitions than any other health system, including national distinctions for surgical care, emergency medicine and orthopedic surgery

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for excellence in specialty care, more than any other health system in the country. The 2027 recognitions reflect clinical outcomes in important areas of patient care, including surgical care, emergency medicine and orthopedic surgery.

For patients and families making healthcare decisions, these recognitions provide information about hospitals that have demonstrated strong clinical outcomes in specific areas of care. Healthgrades evaluates hospitals using measures such as risk-adjusted mortality and complication rates, which account for differences in patients’ health conditions and the complexity of their care.

Among HCA Healthcare hospitals’ 2027 Healthgrades achievements:

  • 102 hospitals received specialty care recognition, the most of any health system nationwide.
  • 56 hospitals earned the Surgical Care Excellence Award, representing the most recipients of any health system in the country.
  • 45 hospitals received the new Emergency Medicine Excellence Award, more than any other health system nationwide. The award recognizes hospitals for clinical outcomes involving serious conditions commonly associated with emergency admissions, including heart attack, stroke and sepsis.
  • 52 hospitals were named among America’s 100 Best Hospitals for Orthopedic Surgery, representing more than half of all hospitals receiving this national distinction.

Across the recognized hospitals, HCA Healthcare received 280 America’s Best Specialty distinctions and 617 Specialty Excellence Awards, both the highest totals among health systems nationwide.

“Patients place an extraordinary amount of trust in the people caring for them, often during some of the most difficult moments in their lives,” said Michael Schlosser, M.D., MBA, executive vice president and chief clinical officer of HCA Healthcare. “These awards reflect the expertise, dedication and teamwork of the physicians, nurses and colleagues who care for our patients every day. They also reinforce our responsibility to keep learning, measuring our performance and finding ways to help make care safer and better for every patient we serve.”

HCA Healthcare supports its caregivers through a connected network designed to enable hospitals to share expertise, learn from clinical data and promote practices to improve patient care. For example, drawing on its system-wide experience of approximately 10 million emergency room visits annually, HCA Healthcare works with clinical teams to identify opportunities for improvement and share best practices across its hospitals. In 2025, the organization also standardized technology across its emergency departments to help care teams have a more complete view of patient information, supporting timely clinical decisions and coordinated care.

The Healthgrades specialty care recognitions are based on an analysis of clinical outcomes for common conditions and procedures. The awards recognize performance in specific specialties by evaluating hospitals using objective clinical measures.

While these recognitions highlight strong performance at individual hospitals, HCA Healthcare remains focused on improving clinical outcomes and the care experience across its network. The organization continues to evaluate performance, identify opportunities for improvement and support caregivers in delivering safe, effective and compassionate care.

To learn more about Healthgrades’ methodology, visit https://www.healthgrades.com/quality/ratings-awards/methodology .

About HCA Healthcare

Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

Source: HCA Healthcare

View All News

Quick Links

IR Contact

615-344-2688

Send Email

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At HCA Healthcare, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to HCA Healthcare to send you the requested Investor Email Alert updates.

* Required

Email Address * Investor Alert Options *

News
Events & Presentations
Annual Reports
SEC Filings
End of Day Stock Quote
Captcha
Enter the code shown above.
*

Submit

Submit

Unsubscribe

Email Alert Sign Up Confirmation

HCA Healthcare Logo

Follow Us

Copyright 1999-2026, C-HCA, Inc; All rights reserved.

California Notice at Collection | Right to Receive Estimate | Terms of Use | Notice of Privacy Practices | Privacy Policy

| Social Media Policy | Acceptable Use Policy | Surprise Billing | Nondiscrimination Notice | Accessibility | Disclosures | Cookie Preferences

Prompts

HCA Healthcare, Inc. (ticker HCA), listed in United States.

Company History

Date Change Detail
May 9, 2017 Renamed HCA HOLDINGS, INC. → HCA HEALTHCARE, INC.
Jul 2, 2001 Renamed HCA THE HEALTHCARE CO → HCA INC/TN
Aug 7, 2000 Renamed COLUMBIA HCA HEALTHCARE CORP → HCA-THE HEALTHCARE CO

ETFs Holding HCA Healthcare, Inc.

ETF Weight in ETF Shares Market value As of
FCTE 5.01% 31,363 $ 12.228M Jun 30, 2026
YALL 4.88% 7,041 $ 3.603M Nov 17, 2026
NEWZ 3.78% 1,568 $ 790K Nov 18, 2026
STNC 3.17% 7,315 $ 2.945M Jul 31, 2026
JPEF 2.91% 112,343 $ 56.305M Nov 17, 2026
ABIG 2.71% 3,208 $ 1.61M Nov 18, 2026
WLTG 2.06% 3,942 $ 1.587M Jul 31, 2026
CPAI 1.95% 18,452 $ 7.194M Jun 30, 2026
PRAY 1.68% 3,375 $ 1.316M Jun 30, 2026
AMID 1.60% 3,710 $ 1.86M Nov 18, 2026
JDOC 1.55% 305 $ 152.863K Nov 17, 2026
FEGE 1.51% 91,325 $ 37.85M Aug 31, 2026
BUSA 1.25% 9,586 $ 3.737M Jun 30, 2026
CBLS short -1.12% -1,546 $ -622.404K Jul 31, 2026
JAVA 1.06% 157,037 $ 78.705M Nov 17, 2026
SURE 1.05% 1,206 $ 604.435K Nov 17, 2026
ACVU 1.05% 5,814 $ 0.00 Nov 18, 2026
LCF 1.04% 1,725 $ 672.56K Jun 30, 2026
TMED 0.95% 562 $ 219.118K Jun 30, 2026
PSET 0.88% 652 $ 254.208K Jun 30, 2026
SEIV 0.86% 32,392 $ 12.629M Jun 30, 2026
AFLG 0.78% 14,011 $ 7.171M Nov 16, 2026
GDMA 0.77% 2,889 $ 1.45M Nov 18, 2026
RFFC 0.72% 566 $ 234.579K Aug 31, 2026
TCAL 0.71% 4,566 $ 2.337M Nov 17, 2026
LCAP 0.71% 33,105 $ 12.907M Jun 30, 2026
WTV 0.66% 49,671 $ 19.366M Jun 30, 2026
MFUT 0.65% 951 $ 486.703K Nov 17, 2026
VFVA 0.53% 12,176 $ 5.046M Aug 31, 2026
VFMF 0.51% 12,105 $ 5.017M Aug 31, 2026
IALT 0.46% 71,212 $ 36.445M Nov 16, 2026
LSVD 0.46% 7,404 $ 2.981M Jul 31, 2026
RGLO 0.45% 3,896 $ 1.519M Jun 30, 2026
CGGR 0.45% 219,168 $ 112.166M Nov 16, 2026
BTAL 0.42% 3,036 $ 1.184M Jun 30, 2026
FLDZ 0.39% 41 $ 15.985K Jun 30, 2026
TVAL 0.39% 8,719 $ 4.462M Nov 17, 2026
ENHU 0.37% 68 $ 34.801K Nov 16, 2026
NANC 0.36% 1,881 $ 962.658K Nov 17, 2026
UPSD 0.33% 972 $ 391.317K Jul 31, 2026
TFPN 0.31% 942 $ 482.097K Nov 17, 2026
FLSP 0.30% 7,357 $ 2.868M Jun 30, 2026
BAMG 0.28% 871 $ 360.986K Aug 31, 2026
CAPE 0.28% 1,717 $ 669.441K Jun 30, 2026
CDX 0.28% 1,353.863 $ 678.543K Nov 17, 2026
SFTY 0.26% 5,023 $ 2.082M Aug 31, 2026
STOX 0.26% 1,422 $ 589.348K Aug 31, 2026
VSLU 0.26% 3,612 $ 1.408M Jun 30, 2026
PEPS 0.24% 180 $ 70.18K Jun 30, 2026
THRO 0.24% 48,615 $ 24.88M Nov 16, 2026
LGDX 0.23% 605 $ 309.627K Nov 17, 2026
MPLY 0.22% 87 $ 35.025K Jul 31, 2026
DYNF 0.18% 142,918 $ 73.143M Nov 16, 2026
APUE 0.17% 10,399 $ 4.31M Aug 31, 2026
XMAG 0.15% 636 $ 318.42K Nov 13, 2026
SFGV 0.15% 3,408 $ 1.71M Nov 18, 2026
GDE 0.14% 1,629 $ 675.139K Aug 31, 2026
NTSX 0.14% 4,722 $ 1.841M Jun 30, 2026
VOXP 0.13% 18 $ 7,246.62 Jul 31, 2026
MODL 0.12% 3,280 $ 1.279M Jun 30, 2026
NTSD 0.12% 114 $ 44.447K Jun 30, 2026
DFUS 0.11% 47,247 $ 23.655M Nov 12, 2026
ACIO 0.11% 6,205 $ 2.498M Jul 31, 2026
ADME 0.10% 751 $ 302.345K Jul 31, 2026
DCOR 0.10% 89,987 $ 45.053M Nov 12, 2026
INRO 0.10% 1,192 $ 610.042K Nov 16, 2026
DFAU 0.10% 25,453 $ 12.743M Nov 12, 2026
ACVF 0.09% 337 $ 135.673K Jul 31, 2026
HCMT 0.08% 1,081 $ 435.2K Jul 31, 2026
TACU 0.07% 26 $ 13.306K Nov 17, 2026
GEW 0.07% 256 $ 106.099K Aug 31, 2026
AVSU 0.07% 684 $ 350.058K Nov 16, 2026
AAUS 0.07% 669 $ 340K Nov 18, 2026
FELV 0.07% 5,732 $ 2.235M Jun 30, 2026
MSLC 0.07% 6,394 $ 2.65M Aug 31, 2026
GSPY 0.06% 749 $ 383.323K Nov 17, 2026
AVUS 0.05% 15,340 $ 7.851M Nov 16, 2026
AVLC 0.05% 1,556 $ 796.33K Nov 16, 2026
CSHP 0.04% 313 $ 160.187K Nov 16, 2026
DFAC 0.04% 63,716 $ 31.9M Nov 12, 2026
DUHP 0.03% 10,329 $ 5.171M Nov 12, 2026
GVLU 0.02% 120 $ 61.414K Nov 17, 2026
DFSU 0.02% 921 $ 461.108K Nov 12, 2026
DXUV 0.00% 99 $ 49.565K Nov 12, 2026
CORO 0.00% 93 $ 47.518K Nov 16, 2026